Differences in primary indication for guide-extension catheter usage among the three target vessels

Ruka Yoshida; Hideki Ishii; Akihito Tanaka; Iwana Inukai; Kensuke Takagi; Toyoaki Murohara

doi:10.5114/aic.2020.96063

Differences in primary indication for guide-extension catheter usage among the three target vessels

Ruka Yoshida
, Hideki Ishii
, Akihito Tanaka
, Iwana Inukai
, Kensuke Takagi
, Toyoaki Murohara

医学部・内科学（第４）

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

3 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	192-197
ページ数	6
ジャーナル	Postepy w Kardiologii Interwencyjnej
巻	16
号	2
DOI	https://doi.org/10.5114/aic.2020.96063
出版ステータス	出版済み - 2020

All Science Journal Classification (ASJC) codes

循環器および心血管医学

文献へのアクセス

10.5114/aic.2020.96063

他のファイルとリンク

引用スタイル

@article{1c04b7595688464e91a38a6cef8695d9,

title = "Differences in primary indication for guide-extension catheter usage among the three target vessels",

author = "Ruka Yoshida and Hideki Ishii and Akihito Tanaka and Iwana Inukai and Kensuke Takagi and Toyoaki Murohara",

note = "Funding Information: shi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd. Department of Cardiology, Nagoya University Graduate School of Medicine received research grants from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingel-heim Co., Ltd., Pfizer Japan Inc., and Teijin Pharma Ltd.",

year = "2020",

doi = "10.5114/aic.2020.96063",

language = "English",

volume = "16",

pages = "192--197",

journal = "Postepy w Kardiologii Interwencyjnej",

issn = "1734-9338",

publisher = "Termedia Publishing House Ltd.",

number = "2",

}

TY - JOUR

T1 - Differences in primary indication for guide-extension catheter usage among the three target vessels

AU - Yoshida, Ruka

AU - Ishii, Hideki

AU - Tanaka, Akihito

AU - Inukai, Iwana

AU - Takagi, Kensuke

AU - Murohara, Toyoaki

N1 - Funding Information: shi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd. Department of Cardiology, Nagoya University Graduate School of Medicine received research grants from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingel-heim Co., Ltd., Pfizer Japan Inc., and Teijin Pharma Ltd.

PY - 2020

Y1 - 2020

UR - https://www.scopus.com/pages/publications/85089001132

UR - https://www.scopus.com/pages/publications/85089001132#tab=citedBy

U2 - 10.5114/aic.2020.96063

DO - 10.5114/aic.2020.96063

M3 - Article

AN - SCOPUS:85089001132

SN - 1734-9338

VL - 16

SP - 192

EP - 197

JO - Postepy w Kardiologii Interwencyjnej

JF - Postepy w Kardiologii Interwencyjnej

IS - 2

ER -